↓ Skip to main content

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Overview of attention for article published in European Heart Journal, August 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
136 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
Published in
European Heart Journal, August 2011
DOI 10.1093/eurheartj/ehr334
Pubmed ID
Authors

Ph. Gabriel Steg, Shamir R. Mehta, J. Wouter Jukema, Gregory Y.H. Lip, C. Michael Gibson, Frantisek Kovar, Petr Kala, Alberto Garcia-Hernandez, Ronny W. Renfurm, Christopher B. Granger

Abstract

To establish the safety, tolerability and most promising regimen of darexaban (YM150), a novel, oral, direct factor Xa inhibitor, for prevention of ischaemic events in acute coronary syndrome (ACS).

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
Japan 1 1%
Spain 1 1%
Unknown 69 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 16%
Researcher 11 15%
Student > Postgraduate 9 12%
Student > Ph. D. Student 8 11%
Student > Bachelor 6 8%
Other 16 22%
Unknown 11 15%
Readers by discipline Count As %
Medicine and Dentistry 37 51%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Agricultural and Biological Sciences 5 7%
Computer Science 4 5%
Chemistry 3 4%
Other 3 4%
Unknown 15 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2014.
All research outputs
#3,426,076
of 12,024,798 outputs
Outputs from European Heart Journal
#2,347
of 5,669 outputs
Outputs of similar age
#81,153
of 273,296 outputs
Outputs of similar age from European Heart Journal
#50
of 98 outputs
Altmetric has tracked 12,024,798 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.7. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,296 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.